SLN
Silence Therapeutics plcCompany with tickers: SLN, SLNCF
CIK
1479615
CUSIP
82686Q101
Shares Outstanding
47,234,613
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $142,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $88,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | — | ||||
| Research & Development | $20,813,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-28,409,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-28,530,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.20 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.20 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |